Expression of activation markers on basophils in a controlled model of anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 5, 2007, Pages 1181-1188

  Gober, Laura M ^a   Eckman, John A ^a   Sterba, Patricia M ^a   Vasagar, Kavitha ^a   Schroeder, John T ^a   Golden, David B K ^a   Saini, Sarbjit S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

activation marker; Anaphylaxis; basophil

Indexed keywords

CD63 ANTIGEN; CD69 ANTIGEN; HISTAMINE; VENOM;

ADULT; ARTICLE; BASOPHIL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HISTAMINE RELEASE; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INSECT STING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANAPHYLAXIS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARTHROPOD VENOMS; BASOPHILS; BIOLOGICAL MARKERS; DESENSITIZATION, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; INSECT BITES AND STINGS; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES;

EID: 34247538087     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.01.008     Document Type: Article

References (35)

1. Sampson H.A., Muñoz-Furlong A., Campbell R.L., Adkinson N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
2. Sampson H.A., Mendelson L., and Rosen J.P. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 327 (1992) 380-384
3. Simons F.E.R. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 117 (2006) 367-377
4. Schwartz L.B., Yunginger J.W., Miller J., Bokhari R., and Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83 (1989) 1551-1555
5. Paris-Kohler A., Demoly P., Persi L., Lebel B., Bousquet J., and Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 105 (2000) 339-345
6. 4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 82 (1999) 33-40
7. Sanz M.L., Gamboa P.M., Antepara I., Uasuf C., Vila L., Garcia-Aviles C., et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reaction to betalactam antibiotics. Clin Exp Allergy 32 (2002) 277-286
8. Binder M., Fierlbeck G., King T.P., Valent P., and Buehring H.J. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol 129 (2002) 160-168
9. Kosnik M., Silar M., Bajrovic E., and Korosec P. High sensitivity of basophils predicts side-effects in venom immunotherapy. Allergy 60 (2005) 1401-1406
10. Eberlein-Koenig B., Schmidt-Leidescher C., Rakoski J., Behrendt H., and Ring J. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. J Investig Allergol Clin Immunol 16 (2006) 5-10
11. Knol E.F., Mul F.P.J., Jansen H., Calafat J., and Roos D. Monitoring human basophil activation via CD63 monoclonal antibody-435. J Allergy Clin Immunol 88 (1991) 328-338
12. Yoshimura C., Yamaguchi M., Iikura M., Izumi S., Kudo K., Nagase H., et al. Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. J Allergy Clin Immunol 109 (2002) 817-823
13. Vasagar K., Vonakis B.M., Gober L.M., Viksman A., Gibbons S.P., and Saini S.S. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy 36 (2006) 770-776
14. Buehring H.J., Seiffert M., Giesert C., Marxer A., Kanz L., Valent P., et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 97 (2001) 3303-3305
15. Boumiza R., Monneret G., Forissier M.F., Savoye J., Gutowski M.C., Powell W.S., et al. Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy 33 (2003) 259-265
16. Hauswirth A.W., Natter S., Ghannadan M., Mailesi Y., Schernthaner G.H., Sperr W.R., et al. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol 110 (2002) 102-109
17. Buehring H.J., Streble A., and Valent P. The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 133 (2004) 317-329
18. Buehring H.J., Simmons P.J., Pudney M., Mueller R., Jarrossay D., van Agthoven A., et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 94 (1999) 2343-2356
19. Golden D.B. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 115 (2005) 439-447
20. Golden D.B.K., Breisch N.L., Hamilton R.G., Guralnick M.W., Greene A., Craig T.J., et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol 117 (2006) 670-675
21. Platz I.J., Binder M., Marxer A., Lischka G., Valent P., and Buehring H.J. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals. Int Arch Allergy Immunol 126 (2001) 335-342
22. Gilbert H.S., and Ornstein L. Basophil counting with a new staining method using alcian blue. Blood 46 (1975) 279-286
23. Schroeder J.T., Schleimer R.P., Lichtenstein L.M., and Kreutner W. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 31 (2001) 1369-1377
24. Saini S., Bloom D.C., Bieneman A., Vasagar K., Togias A., and Schroeder J. Systemic effects of allergen exposure on blood basophil IL-13 secretion and FcεRIβ. J Allergy Clin Immunol 114 (2004) 768-774
25. 4 release. Clin Exp Allergy 30 (2000) 1166-1171
26. Lambert C., Guilloux L., Dzviga C., Gourgaud-Massias C., and Genin C. Flow cytometry versus histamine release analysis of in vitro basophil degranulation in allergy to Hymenoptera venom. Cytometry B Clin Cytom 52 (2003) 13-19
27. Lichtenstein L.M., Norman P.S., and Winkenwerder W.L. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med 44 (1968) 514-524
28. Lie W.J., Knol E.F., Mul F.P.J., Jansen H.M., Roos D., and van der Zee J.S. Basophils from patients with allergic asthma show a primed phenotype. J Allergy Clin Immunol 104 (1999) 1000-1007
29. Hoffman D.R., and Jacobson R.S. Allergies in Hymenoptera venom XII: how much protein is in a sting?. Ann Allergy 52 (1984) 276-278
30. Ebo D.G., Hagendorens M.M., Bridts C.H., Schuerwegh A.J., De Clerck L.S., and Stevens W.J. In vitro allergy diagnosis: should we follow the flow?. Clin Exp Allergy 34 (2004) 332-339
31. Erdmann S.M., Sachs B., Kweicien R., Moll-Slodowy S., Sauer I., and Merk F. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy 59 (2004) 1102-1109
32. Kleine-Tebbe J., Erdmann S., Knol E.F., MacGlashan Jr. D.W., Poulsen L.K., and Gibbs B.F. Diagnostic tests based on human basophils: potentials, pitfalls, and perspectives. Int Arch Allergy Immunol 141 (2006) 79-90
33. Crockard A.D., and Ennis M. Basophil histamine release tests in the diagnosis of allergy and asthma. Clin Exp Allergy 31 (2001) 345-350
34. MacGlashan Jr. D. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 91 (1993) 605-615
35. Lin R.Y., Schwartz L.B., Curry A., Pesola G.R., Knight R.J., Lee H.S., et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 106 (2000) 65-71